PropertyValue
?:abstract
  • INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a pandemic that has affected >188 countries, involved >24 million people, and caused >840,000 deaths. COVID-19, in its severe form, presents as acute respiratory distress syndrome (ARDS), shock, and multiorgan failure. Thrombotic microangiopathy of the lungs and kidneys has been observed in these patients. Elevated D-dimer levels have been observed in people with serious COVID-19 illness, and this could be helpful in guiding treatment with anticoagulation in these patients. OBJECTIVE: To analyze the role of anticoagulation as a treatment modality for COVID-19. METHODS: We present the unique case of a COVID-19 patient who developed sepsis, ARDS, acute kidney injury, and deep-vein thrombosis (DVT), who was deteriorating clinically. She was treated with anticoagulation. RESULTS: There was rapid recovery after treatment with systemic anticoagulation. CONCLUSIONS: Systemic anticoagulation could prove to be essential in the treatment of CO­VID-19. Further studies are required to assess its role in improving long-term morbidity and mortality in these patients.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1159/000511800
?:journal
  • Cardiorenal_Med
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/5ce95105478c76356caf10f8179da2a286e41d9a.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7649692.xml.json
?:pmcid
?:pmid
?:pmid
  • 33091905.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature
?:type
?:year
  • 2020-10-22

Metadata

Anon_0  
expand all